Science Explorer Interactive view Map
Company · Cambridge · United States

Alnylam Pharmaceuticals (United States)

In research, Alnylam Pharmaceuticals (United States) stands highest in Life Sciences (#3,644 of 14,347 worldwide), Molecular Biology (#1,420 of 4,961 worldwide) and Biochemistry, Genetics and Molecular Biology (#2,412 of 7,814 worldwide), over all time. Relative to its size it is most specialised in Molecular Biology and Biochemistry, Genetics and Molecular Biology — Molecular Biology is 12.6× its share of world research.

World rank, 2022–2025
#13,768
of 28,054 · #9,405 all time
Rank in United States
#1,920
of 4,192
Research works
344
▲ 134% vs 2013–17
Citations
25k
73.5 per fractional work
Top-10% rate
18.5%
record average 16.5%
Open access
50%
world 28%

What is Alnylam Pharmaceuticals (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #3,644 of 14,347 34.9%210
Molecular BiologySubfield #1,420 of 4,961 34.9%152
Biochemistry, Genetics and Molecular BiologyField #2,412 of 7,814 35.5%190

Each strip is that field’s whole ranked pool, with the notch where Alnylam Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Alnylam Pharmaceuticals (United States) specialise in?

Where its research is concentrated relative to its size: Molecular Biology takes 12.6× the share of its output that it takes of world research.

  1. Molecular BiologySubfield · 36.0 works13×
  2. Biochemistry, Genetics and Molecular BiologyField · 45.8 works9.1×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.24× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 9.10× its world share, 46 worksBiochemistry, Geneti…Immunology and Microbiology: 2.61× its world share, 2 worksImmunology and Micro…Neuroscience: 0.92× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.15× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.67× its world share, 1 worksChemistryComputer Science: 0.08× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.11× its world share, 0 worksEarth and Planetary …Engineering: 0.12× its world share, 2 worksEngineeringEnvironmental Science: 0.04× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.06× its world share, 0 worksMaterials ScienceMathematics: 0.34× its world share, 0 worksMathematicsPhysics and Astronomy: 0.16× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.02× its world share, 0 worksHealth ProfessionsMedicine: 1.93× its world share, 35 worksMedicineNursing: 1.40× its world share, 1 worksNursingVeterinary: 1.36× its world share, 0 worksVeterinaryArts and Humanities: 0.11× its world share, 0 worksArts and HumanitiesDecision Sciences: 0.91× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.27× its world share, 0 worksEconomics, Econometr…Psychology: 0.17× its world share, 0 worksPsychologySocial Sciences: 0.03× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 9.1×. Every wedge is a field page.

Who are the top researchers at Alnylam Pharmaceuticals (United States)?

Ranked on the composite score, Jared Gollob, Akshay Vaishnaw and Marianne T. Sweetser lead among researchers whose main affiliation is Alnylam Pharmaceuticals (United States).

  1. 1 Jared Gollob United States · #53,636 worldwide 481 citations · 39 works
  2. 2 Akshay Vaishnaw United States · #130,542 worldwide 459 citations · 21 works
  3. 3 Marianne T. Sweetser United States · #172,795 worldwide 446 citations · 18 works
  4. 4 Brian R. Bettencourt United States · #885,797 worldwide 84 citations · 16 works
  5. 5 Joo‐Hwan Kim United States · #1,244,244 worldwide 58 citations · 25 works
All ranked researchers at Alnylam Pharmaceuticals (United States)

Which keywords describe research at Alnylam Pharmaceuticals (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Treatment, Diagnosis, Gene Therapy, Prognosis, Cardiovascular Magnetic Resonance, RNA Interference, siRNA Delivery and Cardiac Amyloidosis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Treatment11▲ 9.5×12 topics
  2. Diagnosis9▲ 10×9 topics
  3. Gene Therapy8▲ 46×3 topics
  4. Prognosis8▲ 26×5 topics
  5. Cardiovascular Magnetic Resonance8▲ 153×2 topics
  6. RNA Interference8▲ 94×1 topic
  7. siRNA Delivery8▲ 135×1 topic
  8. Cardiac Amyloidosis7▲ 372×1 topic
  9. Transthyretin7▲ 372×1 topic
  10. Oxidative Stress7▲ 4.6×17 topics
  11. Inflammation6▲ 3.3×27 topics
  12. Genetic Mutations5▲ 13×8 topics
  13. Vitamin B125▲ 162×2 topics
  14. Nanoparticles5▲ 4.3×6 topics
  15. Metabolic Syndrome5▲ 6.4×10 topics
  16. Biosensors5▲ 9.9×2 topics
  17. DNA nanotechnology5▲ 41×1 topic
  18. Self-Assembly5▲ 16×1 topic
  19. Liver Transplantation5▲ 41×4 topics
  20. Hypertension4▲ 16×9 topics
  21. Cardiovascular Disease4▲ 4.0×13 topics
  22. Genomic Analysis4▲ 18×3 topics
  23. Cancer4▲ 3.1×18 topics
  24. Heme Biosynthesis4▲ 628×1 topic
  25. Porphyrias4▲ 628×1 topic
  26. Risk Factors4▲ 3.5×8 topics
  27. Management3▲ 4.2×4 topics
  28. Chronic Kidney Disease3▲ 14×6 topics
  29. Apoptosis3▲ 9.6×6 topics
  30. Therapeutic Targets3▲ 19×3 topics
  31. Nucleic Acids3▲ 100×2 topics
  32. Antisense Oligonucleotides2▲ 63×2 topics
  33. Cardiovascular Events2▲ 22×2 topics
  34. DNA Structure2▲ 130×1 topic
  35. G-Quadruplexes2▲ 130×1 topic
  36. Neuroprotection2▲ 7.2×4 topics
  37. Mitochondrial Dysfunction2▲ 8.4×7 topics
  38. Parathyroid Hormone2▲ 27×3 topics
  39. FGF232▲ 68×1 topic
  40. phosphate2▲ 68×1 topic

Which research topics does Alnylam Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: RNA Interference and Gene Delivery, Amyloidosis: Diagnosis, Treatment, Outcomes, Advanced biosensing and bioanalysis techniques and Porphyrin Metabolism and Disorders.

  1. 1 RNA Interference and Gene Delivery Molecular Biology 8 works
  2. 2 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 7 works
  3. 3 Advanced biosensing and bioanalysis techniques Molecular Biology 5 works
  4. 4 Porphyrin Metabolism and Disorders Molecular Biology 4 works
  5. 5 DNA and Nucleic Acid Chemistry Molecular Biology 2 works
  6. 6 Parathyroid Disorders and Treatments Nephrology 2 works
  7. 7 Kidney Stones and Urolithiasis Treatments Pulmonary and Respiratory Medicine 2 works
  8. 8 Heme Oxygenase-1 and Carbon Monoxide Molecular Biology 2 works
  9. 9 MicroRNA in disease regulation Cancer Research 2 works
  10. 10 Alzheimer's disease research and treatments Physiology 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.4%not open49.6%

World: 28% of research is openly available.

with international co-authors31.0%domestic only69.0%

World: 19% is written across borders.

How has Alnylam Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 134% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.